Top Markets
#1 Seeker Seeker +134.80%
#2 AI XOVIA AI XOVIA +105.87%
#3 MowCat MowCat +70.14%
#4 Helium Helium +65.13%
#5 Cortex Cortex +62.84%
#6 Pons Pons +37.19%
#7 UnifAI Network UnifAI Network +32.97%
#8 Zora Zora +27.86%
#9 Zylo Ecosystem Zylo Ecosystem +20.74%
#10 Bounce Bounce +16.77%
Coin of the day
Seeker Seeker
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Rangering i aksjer #11956
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Aksjekurs
$10.30
Sist synkronisert: 2026-08-11
Markedsverdi
$638.32M
Endring (1 dag)
2.88%
Endring (1 år)
-
Land
CA
Handel Cybin Inc. Common Stock (HELP)

Kategori

Healthcare
P/B-forhold for Cybin Inc. Common Stock (HELP)
P/B-forhold per 2026 TTM: 0
Ifølge Cybin Inc. Common Stock sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Cybin Inc. Common Stock fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH